Health Products

ACT Oxycodone CR (2017-03-15)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
K39640
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
D. ACT Oxycodone CR 40 mgTablet (Extended-Release)DIN 02394200Oxycodone Hydrochloride 40 mg
K42365
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
E. ACT Oxycodone CR 80 mgTablet (Extended-Release)DIN 02394219Oxycodone Hydrochloride 80 mg
K42363
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
B. ACT Oxycodone CR 10 mgTablet (Extended-Release)DIN 02394189Oxycodone Hydrochloride 10 mg
K40870
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
C. ACT Oxycodone CR 20 mgTablet (Extended-Release)DIN 02394197Oxycodone Hydrochloride 20 mg
K45622
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
A. ACT Oxycodone CR 5 mgTablet (Extended-Release)DIN 02394170Oxycodone Hydrochloride 5 mg

Introduction

Affected Products

A. ACT Oxycodone CR 5 mg
B. ACT Oxycodone CR 10 mg
C. ACT Oxycodone CR 20 mg
D. ACT Oxycodone CR 40 mg
E. ACT Oxycodone CR 80 mg

Reason

Affected lot may contain incorrect strength.

Depth of distribution

Retailers
British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, Newfoundland, New Brunswick
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime